Enlie Pharmaceutical Joint Stock Company
Sector: Manufacturing
Industry: Chemical - Pharmaceutical

Open
High
Low
Vol
Market Cap.
Remain Bid
Remain Ask
52Wk High
52Wk Low
52Wk Avg Vol
Foreign Buy
Frgn Owned(%)
Dividend
Dividend Yield
Beta
EPS
P/E
F P/E
BVPS
P/B
 
 
Overview
 
Profile
 
Financials
 
News & Events
 
Documents
 
Compare
 
History price
DatePriceChangeVolumeAvg. BuyAvg. SellForeign BuyForeign Sell
28/03/25 11,200 0(0.00%) 0-1,714.29--
27/03/25 11,200 0(0.00%) 0-740--
26/03/25 11,200 0(0.00%) 0-1,640--
25/03/25 11,200 0(0.00%) 1-1,300--
24/03/25 11,200 0(0.00%) 0-1,660--
Financials
Industry Peers
  News
BCP: Board Resolution
BCP: Board Resolution
BCP: Reviewed Semi-annual Financial Statements 2024
BCP: Reviewed semi-annual financial statement 2024 (holding company)
BCP: Annual General Mandate 2024
BCP: Board Resolution
BCP: Board Resolution
  Download documents
   BCP: Annual report 2024
   BCP: Audited Parent Company FS 2024
   BCP: Audited Consolidated FS 2024
   BCP: Corporate Governance Report 2024
   BCP: Reviewed Consolidated FS the first 6 month of 2024
  Overview
Contact Listing Inf. Business Reg. Additional Inf. Events Notes
Exchange UPCoM
Sector Manufacturing
Industry Chemical - Pharmaceutical
Listing date 09/14/2015
Chartered capital 60,000,000,000
Shares listed 6,000,000
Shares outstanding 6,000,000